Senior Director, Value & Access (Pharmaceutical / Payer) at The Lockwood Group, LLC

Remote

The Lockwood Group, LLC Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, Payer, Life Sciences, ConsultingIndustries

Requirements

Candidates must have proven experience in market access, pricing strategy, or health economics within the life sciences industry. A strong understanding of payer dynamics, reimbursement pathways, and value-based contracting models is essential. Exceptional communication skills are required to synthesize complex data into clear, actionable insights. Demonstrated success in client engagement, strategic planning, and cross-functional collaboration is necessary. The ability to lead high-visibility projects and influence senior stakeholders is also required. An advanced degree in health policy, business, life sciences, or a related field is preferred.

Responsibilities

The Senior Director, Value & Access will serve as a senior advisor and strategic leader, guiding clients through complex market access challenges in the life sciences sector. This role is responsible for developing and executing innovative access strategies informed by deep marketplace knowledge and payer insights. The Senior Director will collaborate closely with account leads, consultants, and business development teams to deliver actionable solutions that drive product access and commercial success. Key responsibilities include leading the design and implementation of market access strategies across pricing, contracting, reimbursement, and value-based frameworks, providing expert assessments of therapeutic value, and overseeing project delivery by offering strategic direction, developing content, and reviewing client-facing materials. The role also involves conducting market access landscape evaluations, competitor simulations, and payer engagement strategies, developing communications tailored to healthcare decision-makers and stakeholders, and supporting business development efforts by contributing to sales strategy, refining presentation content, and engaging with prospective clients.

Skills

Market Access
Pricing Strategy
Health Economics
Payer Dynamics
Reimbursement Pathways
Value-Based Contracting
Life Sciences
Consulting
Strategic Planning
Communication

The Lockwood Group, LLC

Healthcare consulting for drug development support

About The Lockwood Group, LLC

The Lockwood Group provides consulting services specifically for the healthcare and pharmaceutical industries, focusing on clients in the later stages of drug development, particularly after Phase 2 clinical trials. The company assists pharmaceutical and biotech firms by creating strategic publication plans that communicate scientific data and research findings accurately and in compliance with regulatory standards. They also support clients during the prelaunch phase of their products by identifying market needs and collaborating through the launch process to ensure success. A unique aspect of The Lockwood Group is its medical animation affiliate, Random42, which produces engaging and scientifically accurate visual content to help convey complex information. Their business model is based on service fees for consulting and project work, with a commitment to delivering high-quality communications and strategic support to help clients thrive in the competitive healthcare landscape.

Stamford, ConnecticutHeadquarters
2007Year Founded
ACQUISITIONCompany Stage
Consulting, HealthcareIndustries
201-500Employees

Benefits

Remote Work Options
Flexible Work Hours

Risks

Emerging firms using AI-driven content creation threaten market share.
Pharmaceutical companies developing in-house teams may reduce demand for external services.
Tightening EU regulatory standards could increase compliance costs.

Differentiation

Specializes in healthcare and pharmaceutical sectors, focusing on advanced drug development stages.
Offers strategic publication plans tailored to specific audiences and regulatory standards.
Provides commercial support during prelaunch, launch, and post-launch phases.

Upsides

Increased demand for digital health solutions boosts growth in medical communications.
Rise of personalized medicine creates opportunities for specialized communication strategies.
Integration of AI enhances publication strategies and data analysis capabilities.

Land your dream remote job 3x faster with AI